Source: United Kingdom – Executive Government & Departments
Increased discussion of suspected adverse events in social media following use of Arthramid Vet in horses.
We have identified an increase in social media discussion around suspected adverse event reports following use of Arthramid Vet in horses.
Arthramid Vet is an intra-articular polyacrylamide gel used in the treatment of osteoarthritis, synovitis and capsulitis. It is used via the veterinary medicines cascade. A Special Import Certificate is required for use – Apply to import a medicine.
These reports often include worsening of lameness and injection site reactions.
We are closely monitoring adverse event reports received by the VMD.
Reporting of adverse events
We strongly encourage anyone who is aware of an adverse event to report to the Marketing Authorisation Holder or directly to us via our online reporting form. Provide all relevant information, including the batch number.
The reporting of adverse events is critical to our ongoing monitoring activities in order to protect animal health, public health, and the environment. Find out more about pharmacovigilance at VMD Connect – Adverse Events and Pharmacovigilance.